KXTbio is an expert at producing ultra-pure proteins for crystallography and studying protein-protein interactions. The company is uniquely positioned as one of a handful of companies that provides highly purified and activity specific GPCRs, GTPases, G-proteins, and effector proteins, thereby addressing both current and emerging drug discovery needs.
KXTbio’s protein product portfolio currently consists of expression vectors for over 1,000 mutant and wild-type GPCRs, GTPases and proteins within this signaling pathway.
In particular KXTbio has access to state-of-the art protein expression and purification capabilities including:
- insect
- bacterial
- plant
- mammalian
- yeast expression systems
